(Q47284487)

English

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. (English)

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

0 references

0 references

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

author name string

L Sjöström

1

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

A Rissanen

2

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

T Andersen

3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

M Boldrin

4

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

A Golay

5

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

H P Koppeschaar

6

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

352

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

167-172

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

9123

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

The ultimate triumph of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in body mass index and prevalence of obesity in Swedish women 1980-89.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Time trends in obesity: an epidemiological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18–0647 (tetrahydrolipstatin)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS Intervention Study. Swedish Obese Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

International trial of long-term dexfenfluramine in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Diet pills redux

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911509-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(97)11509-4

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9683204

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47284487&oldid=1510062467"